These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7365741)

  • 21. Clionasterol: a potent inhibitor of complement component C1.
    Cerqueira F; Watanadilok R; Sonchaeng P; Kijjoa A; Pinto M; Quarles van Ufford H; Kroes B; Beukelman C; Nascimento MS
    Planta Med; 2003 Feb; 69(2):174-6. PubMed ID: 12624828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of exo affinity labeling reagents.
    Cory M; Andrews JM; Bing DH
    Methods Enzymol; 1977; 46():115-30. PubMed ID: 909401
    [No Abstract]   [Full Text] [Related]  

  • 23. Design, synthesis, and biological activity of diiminoisoindolines as complement component 3a antagonists.
    Grant EB; Guiadeen D; Singer M; Argentieri D; Hlasta DJ; Wachter M
    Bioorg Med Chem Lett; 2001 Nov; 11(21):2817-20. PubMed ID: 11597407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Modification of proteolytic complement cascade after treatment with exogenous heparin].
    Galebskaia LV; Solovtsova IL; Riumina EV
    Vopr Med Khim; 2001; 47(1):91-7. PubMed ID: 11386002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual function of insoluble polyanions. Formation of C1 and C42 sites in addition to activation of the alternative pathway of complement.
    Burger R; Loos M; Kossorotow A; Hadding U; Bitter-Suermann D
    Monogr Allergy; 1977; 12():78-81. PubMed ID: 917023
    [No Abstract]   [Full Text] [Related]  

  • 26. Purification of a human alternative complement pathway inhibitor from hemolymph of larval fall armyworm (Spodoptera frugiperda).
    D'Cruz OJ; Day NK
    Biochem Biophys Res Commun; 1984 Aug; 122(3):1426-33. PubMed ID: 6477568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Functions and structure of complement inactivators in plasma. 1). C1 inhibitor].
    Yonemasu K
    Nihon Rinsho; 1988 Sep; 46(9):1899-903. PubMed ID: 3266510
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological manipulation of complement system.
    Asghar SS
    Pharmacol Rev; 1984 Dec; 36(4):223-44. PubMed ID: 6395140
    [No Abstract]   [Full Text] [Related]  

  • 29. Action of a new non-steroid anti-inflammatory drug, carprofen (Ro 20-5720) on activation of the complement system: an in vitro research.
    Auteria A; Laghi Pasini F; Di Perri T
    Int J Tissue React; 1982; 4(1):9-13. PubMed ID: 7085003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement inhibitor(s) released by leukocytes. III. Evidence for a "new" C1 inhibitor in the supernatants of short-term cultures of mouse spleen and thymus cells.
    Bernard A; Boumsell L; Borsos
    J Immunol; 1975 Oct; 115(4):1091-4. PubMed ID: 1176767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of some hydroxycoumarins on complement-mediated hemolysis in human serum.
    Ivanovska N; Yossifova T; Vassileva E; Kostova I
    Methods Find Exp Clin Pharmacol; 1994 Oct; 16(8):557-62. PubMed ID: 7760580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salt-sensitivity of complement (C)-consumption induced by anticomplementary antigens and antigen/antibody complexes.
    Gancevici G; Popescu C; Toporan M
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):239-50. PubMed ID: 6818928
    [No Abstract]   [Full Text] [Related]  

  • 33. A novel series of potent and selective small molecule inhibitors of the complement component C1s.
    Subasinghe NL; Ali F; Illig CR; Jonathan Rudolph M; Klein S; Khalil E; Soll RM; Bone RF; Spurlino JC; DesJarlais RL; Crysler CS; Cummings MD; Morris PE; Kilpatrick JM; Sudhakara Babu Y
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3043-7. PubMed ID: 15149641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simplified procedure for the purification of C1-inactivator from human plasma. Interaction with complement subcomponents C1r and C1s.
    Reboul A; Arlaud GJ; Sim RB; Colomb MG
    FEBS Lett; 1977 Jul; 79(1):45-50. PubMed ID: 891934
    [No Abstract]   [Full Text] [Related]  

  • 35. [Protein chemistry of the complement system].
    Nagasawa S
    Tanpakushitsu Kakusan Koso; 1983 Jan; 28(1):18-44. PubMed ID: 6340167
    [No Abstract]   [Full Text] [Related]  

  • 36. Modulation of complement by autoimmune antibodies isolated from sera of patients with membranoproliferative glomerulonephritis and systemic lupus erythematosus.
    Daha MR; Van Es LA
    Neth J Med; 1982; 25(7):202-7. PubMed ID: 6924073
    [No Abstract]   [Full Text] [Related]  

  • 37. Activation of first component of complement (C1) in guinea pig serum by a polysaccharide is prevented by C1 inhibitor.
    Schultz DR; Arnold PI
    J Immunol; 1981 Apr; 126(4):1558-61. PubMed ID: 7204976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of low molecular weight compounds with complement inhibition activity.
    Master HE; Khan SI; Poojari KA
    Bioorg Med Chem; 2005 Aug; 13(16):4891-9. PubMed ID: 15978815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Homeostasis of the complement system--complement inhibitors].
    Nagaki K
    Nihon Rinsho; 1979 May; 37(5):969-76. PubMed ID: 381728
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro effects of organic solvents on immunity indicators in serum.
    Stefanovic J; Starsia Z; Murgasová I; Absolonová O
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):1-7. PubMed ID: 3571967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.